Your browser doesn't support javascript.
loading
Case Report: Secondary Hemophagocytic Lymphohistiocytosis With Disseminated Infection in Chronic Granulomatous Disease-A Serious Cause of Mortality.
Squire, Jacqueline D; Vazquez, Stephanie N; Chan, Angela; Smith, Michele E; Chellapandian, Deepak; Vose, Laura; Teppa, Beatriz; Hanson, I Celine; Chinn, Ivan K; Forbes-Satter, Lisa; Seeborg, Filiz O; Nicholas, Sarah K; Martinez, Caridad A; Allen, Carl E; Connors, Thomas J; Satwani, Prakash; Shtessel, Maria; Ale, Hanadys; Noroski, Lenora M; Rider, Nicholas L; Milner, Joshua D; Leiding, Jennifer W.
Affiliation
  • Squire JD; Division of Allergy and Immunology, Department of Pediatrics, University of South Florida, St. Petersburg, FL, United States.
  • Vazquez SN; Graduate Medical Education, Memorial Healthcare System, Hollywood, FL, United States.
  • Chan A; Division of Allergy/Immunology and Rheumatology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, United States.
  • Smith ME; Division of Critical Care Medicine, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, United States.
  • Chellapandian D; Blood and Marrow Transplant, Johns Hopkins-All Children's Hospital, St. Petersburg, FL, United States.
  • Vose L; Critical Care Medicine, Johns Hopkins-All Children's Hospital, St. Petersburg, FL, United States.
  • Teppa B; Critical Care Medicine, Johns Hopkins-All Children's Hospital, St. Petersburg, FL, United States.
  • Hanson IC; Sections of Immunology Allergy and Retrovirology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
  • Chinn IK; Sections of Immunology Allergy and Retrovirology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
  • Forbes-Satter L; Sections of Immunology Allergy and Retrovirology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
  • Seeborg FO; Sections of Immunology Allergy and Retrovirology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
  • Nicholas SK; Sections of Immunology Allergy and Retrovirology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
  • Martinez CA; Division of Pediatric Hematology/Oncology, Texas Children's Hospital Cancer Center, Houston, TX, United States.
  • Allen CE; Division of Pediatric Hematology/Oncology, Texas Children's Hospital Cancer Center, Houston, TX, United States.
  • Connors TJ; Division of Critical Care Medicine, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, United States.
  • Satwani P; Division of Hematology/Oncology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, United States.
  • Shtessel M; Division of Allergy/Immunology and Rheumatology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, United States.
  • Ale H; Division of Allergy and Immunology, Joe DiMaggio Children's Hospital, Hollywood, FL, United States.
  • Noroski LM; Sections of Immunology Allergy and Retrovirology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
  • Rider NL; Sections of Immunology Allergy and Retrovirology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
  • Milner JD; Division of Allergy/Immunology and Rheumatology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, United States.
  • Leiding JW; Division of Allergy and Immunology, Department of Pediatrics, University of South Florida, St. Petersburg, FL, United States.
Front Immunol ; 11: 581475, 2020.
Article in En | MEDLINE | ID: mdl-33362767
ABSTRACT
Chronic granulomatous disease (CGD) is a primary immune deficiency due to defects in phagocyte respiratory burst leading to severe and life-threatening infections. Patients with CGD also suffer from disorders of inflammation and immune dysregulation including colitis and granulomatous lung disease, among others. Additionally, patients with CGD may be at increased risk of systemic inflammatory disorders such as hemophagocytic lymphohistiocytosis (HLH). The presentation of HLH often overlaps with symptoms of systemic inflammatory response syndrome (SIRS) or sepsis and therefore can be difficult to identify, especially in patients with a primary immune deficiency in which incidence of infection is increased. Thorough evaluation and empiric treatment for bacterial and fungal infections is necessary as HLH in CGD is almost always secondary to infection. Simultaneous treatment of infection with anti-microbials and inflammation with immunosuppression may be needed to blunt the hyperinflammatory response in secondary HLH. Herein, we present a series of X-linked CGD patients who developed HLH secondary to or with concurrent disseminated CGD-related infection. In two patients, CGD was a known diagnosis prior to development of HLH and in the other two CGD was diagnosed as part of the evaluation for HLH. Concurrent infection and HLH were fatal in three; one case was successfully treated, ultimately receiving hematopoietic stem cell transplantation. The current literature on presentation, diagnosis, and treatment of HLH in CGD is reviewed.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphohistiocytosis, Hemophagocytic / Granulomatous Disease, Chronic Type of study: Etiology_studies / Prognostic_studies Limits: Adolescent / Humans / Infant / Male Language: En Journal: Front Immunol Year: 2020 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphohistiocytosis, Hemophagocytic / Granulomatous Disease, Chronic Type of study: Etiology_studies / Prognostic_studies Limits: Adolescent / Humans / Infant / Male Language: En Journal: Front Immunol Year: 2020 Document type: Article Affiliation country: United States